Reduced Palmitoylation of SQSTM1 /p62 in Huntington Disease Is Associated With Impaired Autophagy
The FASEB Journal · 15.05.2025 · 39 (9)
DOI: 10.1096/fj.202401781r ↗Kurz gefasst
Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 06.05.2025. Verfasst von F Abrar und 12 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, University of Waterloo, Waterloo, Ontario, Canada. Hauptthemen laut MEDLINE: Huntington Disease, Autophagy, Sequestosome-1 Protein, Lipoylation. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The Royal Society, Canadian Government|Natural Sciences and Engineering Research Council of Canada (NSERC), CIHR.
Abstract (Originalsprache)
Disruption of autophagy has emerged as a common feature in many neurodegenerative diseases. Autophagy is a membrane‐dependent pathway that requires many key regulators to quickly localize on and off membranes during induction, promoting membrane fusion. Previously, our bioinformatic approaches have shown that autophagy and Huntington disease (HD) are enriched in palmitoylated proteins. Palmitoylation involves the reversible addition of long‐chain fatty acids to promote membrane binding. Herein, we show that inhibition of palmitoylation regulates the abundance of several key regulators of autophagy and leads to a partial block of autophagic flux. We confirm that the autophagy receptor SQSTM1/p62 (sequestosome 1) is palmitoylated and directed to the lysosome. Importantly, we report that SQSTM1 palmitoylation is significantly reduced in HD patient and mouse model brains. This finding reveals a novel mechanism contributing to the generation of empty autophagosomes previously seen in HD models and patient‐derived cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Biology, University of Waterloo, Waterloo, Ontario, Canada.
- Molecular and Cell Biology Cluster, School of Biosciences, University of Sheffield, Sheffield, UK.
- Department of Medical Genetics, BC Children's Hospital Research Institute, Centre for Molecular Medicine and Therapeutics, University of British Columbia, Vancouver, British Columbia, Canada.
- Cancer Biology Division, Functional Proteomics, Chester Beatty Laboratories, The Institute of Cancer Research, London, UK.
ORCID-Profile: M O Collins, D D O Martin
Förderung
- The Royal Society
- Canadian Government|Natural Sciences and Engineering Research Council of Canada (NSERC)
- CIHR
- Royal Society
- Natural Sciences and Engineering Research Council of Canada
- Canadian Institutes of Health Research
Zitieren
APA
Abrar, F., Davies, M. C., Alshehabi, Y., Kumar, A., Dang, A., Nguyen, Y. T. N., Collins, J., Caron, N. S., Choudhary, J. S., Sanders, S. S., Collins, M. O., Hayden, M. R., & Martin, D. D. O. (2025). Reduced Palmitoylation of SQSTM1 /p62 in Huntington Disease Is Associated With Impaired Autophagy. The FASEB Journal, 39(9). https://doi.org/10.1096/fj.202401781r
Vancouver
Abrar F, Davies MC, Alshehabi Y, Kumar A, Dang A, Nguyen YTN, et al. Reduced Palmitoylation of SQSTM1 /p62 in Huntington Disease Is Associated With Impaired Autophagy. The FASEB Journal. 2025;39(9). doi:10.1096/fj.202401781r
BibTeX
@article{Abrar2025,
author = {Abrar, F and Davies, M C and Alshehabi, Y and Kumar, A and Dang, A and Nguyen, Y T N and Collins, J and Caron, N S and Choudhary, J S and Sanders, S S and Collins, M O and Hayden, M R and Martin, D D O},
title = {Reduced Palmitoylation of SQSTM1 /p62 in Huntington Disease Is Associated With Impaired Autophagy},
journal = {The FASEB Journal},
year = {2025},
volume = {39},
number = {9},
doi = {10.1096/fj.202401781r}
}
EUVIMED